{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:42:06Z","timestamp":1790959326862,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1002\/jps.20666","type":"journal-article","created":{"date-parts":[[2006,5,25]],"date-time":"2006-05-25T17:28:44Z","timestamp":1148578124000},"page":"1405-1413","source":"Crossref","is-referenced-by-count":45,"title":["Deep Percutaneous Penetration into Muscles and Joints"],"prefix":"10.1016","volume":"95","author":[{"given":"Christine M.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard I.","family":"Maibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20666_bb0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/j.1552-4604.1991.tb01895.x","article-title":"Drug delivery systems. 6. Transdermal drug delivery","volume":"31","author":"Ranade","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"10.1002\/jps.20666_bb0015","first-page":"144","article-title":"Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application","volume":"268","author":"Singh","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.20666_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0378-5173(01)00878-X","article-title":"Targeting of salicylate to skin and muscle following topical injections in rats","volume":"231","author":"Yoshida","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20666_bb0025","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/jps.2600721203","article-title":"Drug delivery to local subcutaneous structures following topical administration","volume":"72","author":"Guy","year":"1983","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20666_bb0030","series-title":"Percutaneous Absorption: Drugs-Cosmetics-Mechanisms-Methodology","first-page":"597","article-title":"Percutaneous penetration as a method of delivery to skin and underlying tissues","author":"Singh","year":"1999"},{"key":"10.1002\/jps.20666_bb0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(05)63324-7","article-title":"Is there tissue penetration after application of topical salicylate formulations?","volume":"350","author":"Cross","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/jps.20666_bb0040","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.2042-7158.1994.tb03250.x","article-title":"Deep tissue penetration of bases and steroids after dermal application in rat","volume":"46","author":"Singh","year":"1994","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.20666_bb0045","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jps.2600730739","article-title":"Penetration of trolamine salicylate into the skeletal muscle of the pig","volume":"73","author":"Baldwin","year":"1984","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20666_bb0050","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.2042-7158.1995.tb03266.x","article-title":"Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats","volume":"47","author":"Megwa","year":"1995","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.20666_bb0055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.2042-7158.1977.tb11434.x","article-title":"Permeability of human epidermis to phenolic compounds","volume":"29","author":"Roberts","year":"1977","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.20666_bb0060","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/jps.2600731006","article-title":"Drug permeation through human skin: II. Permeability of ionizable compounds","volume":"73","author":"Swarbrick","year":"1984","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20666_bb0065","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.0022-202X.2004.22413.x","article-title":"Molecular size as the main determinant of solute maximum flux across the skin","volume":"122","author":"Magnusson","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1002\/jps.20666_bb0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(02)00084-4","article-title":"Estimation of intradermal disposition kinetics of drugs: II. Factors determining penetration of drugs from viable skin to muscular layer","volume":"239","author":"Higaki","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20666_bb0075","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1248\/bpb.21.1195","article-title":"Factors determining drug residence in skin during transdermal absorption: Studies on beta-blocking agents","volume":"21","author":"Yagi","year":"1998","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.20666_bb0080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF01061687","article-title":"Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application","volume":"21","author":"Singh","year":"1993","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1002\/jps.20666_bb0085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1248\/cpb.47.749","article-title":"Skin disposition of drug after topical application in hairless rats","volume":"47","author":"Yanagimoto","year":"1999","journal-title":"Chem Pharm Bull"},{"key":"10.1002\/jps.20666_bb0090","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2125.1991.tb05576.x","article-title":"Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease","volume":"31","author":"Radermacher","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/jps.20666_bb0095","first-page":"1833","article-title":"Transdermal penetration of diclofenac after multiple epicutaneous administration","volume":"25","author":"Muller","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1002\/jps.20666_bb0100","first-page":"1092","article-title":"Die perkutane Resorption von Diclofenav","volume":"36","author":"Riess","year":"1986","journal-title":"Arzneim-Forsch\/Drug Res"},{"key":"10.1002\/jps.20666_bb0105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/j.1552-4604.1984.tb02764.x","article-title":"Absorption of labeled triethanolamine salicylate in human and canine knee joints. II","volume":"24","author":"Rabinowitz","year":"1984","journal-title":"J Clin Pharmacol"},{"key":"10.1002\/jps.20666_bb0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-5173(82)90048-5","article-title":"A pharmacokinetic model for percutaneous absorption","volume":"11","author":"Guy","year":"1982","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20666_bb0115","series-title":"Pharmaceutics: the science of dosage form design","first-page":"499","article-title":"Transdermal drug delivery","author":"Barry","year":"1988"},{"key":"10.1002\/jps.20666_bb0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijpharm.2004.09.025","article-title":"Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin","volume":"288","author":"Higaki","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20666_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jps.2600820203","article-title":"Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures","volume":"82","author":"Singh","year":"1993","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20666_bb0130","first-page":"2002","article-title":"Equivalence study of a topical diclofenac solution (Pennsaid\u00ae) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: A randomized controlled trial","volume":"31","author":"Tugwell","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1002\/jps.20666_bb0135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/(SICI)1099-081X(199710)18:7<623::AID-BDD46>3.0.CO;2-V","article-title":"Pharmacokinetic and local tissue disposition studies of naproxen following topical and systemic administration in dogs and rats","volume":"18","author":"Suh","year":"1997","journal-title":"Biopharm Drug Dispos"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916320524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916320524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:41:05Z","timestamp":1555634465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916320524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0022354916320524"],"URL":"https:\/\/doi.org\/10.1002\/jps.20666","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}